Correlation Between Syndax Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Spyre Therapeutics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Syndax and Spyre is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.86 times more return on investment than Spyre Therapeutics. However, Syndax Pharmaceuticals is 1.16 times less risky than Spyre Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 1,277 in Syndax Pharmaceuticals on December 27, 2024 and sell it today you would earn a total of 36.00 from holding Syndax Pharmaceuticals or generate 2.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Spyre Therapeutics
Performance |
Timeline |
Syndax Pharmaceuticals |
Spyre Therapeutics |
Syndax Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Spyre Therapeutics vs. Gladstone Investment | Spyre Therapeutics vs. Greentown Management Holdings | Spyre Therapeutics vs. Gfl Environmental Holdings | Spyre Therapeutics vs. Fidus Investment Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |